FCF1P3

Across TCGA pan-cancer cohorts, FCF1P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FCF1P3’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where FCF1P3 RNA is repressed in tumor relative to normal tissue. In most cancer types FCF1P3 is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

THCA, LUAD, and LUSC are the cancer types where FCF1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FCF1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.070	<.001	6	view →
LUAD	Female	II,III,IV	−0.082	.017	1	view →
LUSC	Female	All	−0.046	.034	1	view →
KICH	All	II,III,IV	−0.040	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

FCF1P3–THCA

Open the THCA breakdown →